Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Huang

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Dalton Transactions (Cambridge, England : 2003)|July 24, 2024
Steric and electronic influence on Cu-Cu short contacts in β-thioketiminato tricopper(I) clustersVenkata Sai Sashankh Penki, Yu-Ting Chu, Hsing-Yin Chen, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|April 30, 2025
Novel blue-pea flowers derived-carbon dots/iron oxide nanohybrid as sustainable "turn-off" fluorescent nanosensor for selective Fe<sup>3+</sup> detection in food samplesPattaraporn Nuntahirun, Chien-Hung Li, Natee Sirisit, et al.
Journal of Patient-Reported Outcomes|November 14, 2023
Qualitative and psychometric evaluation of the PROMIS®-Fatigue SF-7a scale to assess fatigue in patients with moderately to severely active inflammatory bowel diseaseBrian G Feagan, William J Sandborn, Bruce E Sands, et al.
Antiviral Therapy|November 18, 2009
Prevalence of HIV type-1 drug-associated mutations in pre-therapy patients in the Free State, South AfricaKuan-Hsiang Gary Huang, Dominique Goedhals, Helen Fryer, et al.
Nature Communications|July 11, 2019
Mapping the drivers of within-host pathogen evolution using massive data setsDuncan S Palmer, Isaac Turner, Sarah Fidler, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 6, 2024
Qualitative and Psychometric Evaluation of 29-Item Patient-Reported Outcomes Measurement Information System® to Assess General Health-Related Quality of Life in Patients With Moderately to Severely Active Inflammatory Bowel DiseaseBruce E Sands, Julian Panés, Brian G Feagan, et al.
Journal of Virology|September 11, 2009
Full-length characterization of hepatitis C virus subtype 3a reveals novel hypervariable regions under positive selection during acute infectionIsla Humphreys, Vicki Fleming, Paolo Fabris, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 17, 2025
A Model-Based Meta-Analysis Framework Quantifying Drivers of Placebo Response in Atopic Dermatitis TrialsJean C Serrano, John Maringwa, Roel Straetemans, et al.
Arthritis Research & Therapy|April 22, 2023
The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb studyPaul Emery, Yoshiya Tanaka, Vivian P Bykerk, et al.
Rheumatology and Therapy|March 3, 2023
Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid ArthritisPaul Emery, Yoshiya Tanaka, Vivian P Bykerk, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Dalton Transactions (Cambridge, England : 2003)|July 24, 2024
Steric and electronic influence on Cu-Cu short contacts in β-thioketiminato tricopper(I) clustersVenkata Sai Sashankh Penki, Yu-Ting Chu, Hsing-Yin Chen, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|April 30, 2025
Novel blue-pea flowers derived-carbon dots/iron oxide nanohybrid as sustainable "turn-off" fluorescent nanosensor for selective Fe<sup>3+</sup> detection in food samplesPattaraporn Nuntahirun, Chien-Hung Li, Natee Sirisit, et al.
Journal of Patient-Reported Outcomes|November 14, 2023
Qualitative and psychometric evaluation of the PROMIS®-Fatigue SF-7a scale to assess fatigue in patients with moderately to severely active inflammatory bowel diseaseBrian G Feagan, William J Sandborn, Bruce E Sands, et al.
Antiviral Therapy|November 18, 2009
Prevalence of HIV type-1 drug-associated mutations in pre-therapy patients in the Free State, South AfricaKuan-Hsiang Gary Huang, Dominique Goedhals, Helen Fryer, et al.
Nature Communications|July 11, 2019
Mapping the drivers of within-host pathogen evolution using massive data setsDuncan S Palmer, Isaac Turner, Sarah Fidler, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 6, 2024
Qualitative and Psychometric Evaluation of 29-Item Patient-Reported Outcomes Measurement Information System® to Assess General Health-Related Quality of Life in Patients With Moderately to Severely Active Inflammatory Bowel DiseaseBruce E Sands, Julian Panés, Brian G Feagan, et al.
Journal of Virology|September 11, 2009
Full-length characterization of hepatitis C virus subtype 3a reveals novel hypervariable regions under positive selection during acute infectionIsla Humphreys, Vicki Fleming, Paolo Fabris, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 17, 2025
A Model-Based Meta-Analysis Framework Quantifying Drivers of Placebo Response in Atopic Dermatitis TrialsJean C Serrano, John Maringwa, Roel Straetemans, et al.
Arthritis Research & Therapy|April 22, 2023
The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb studyPaul Emery, Yoshiya Tanaka, Vivian P Bykerk, et al.
Rheumatology and Therapy|March 3, 2023
Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid ArthritisPaul Emery, Yoshiya Tanaka, Vivian P Bykerk, et al.
Pageof 8